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Malnutrition in HIV/AIDS: 
Aetiopathogenesis
Vangal K. Sashindran and Rajneesh Thakur
Abstract
HIV/AIDS can cause malnutrition directly and also indirectly through oppor-
tunistic infections (OIs). Infectious diarrhoea and tuberculosis are the commonest 
OIs linked to malnutrition in HIV/AIDS. Environmental enteric dysfunction has 
now been identified to play a significant role in HIV-malnutrition. Food insecurity 
is bidirectionally associated with aggravation and perpetuation of HIV infection. 
Increasingly, drugs used in antiretroviral therapy have been recognised to lead 
malnutrition in many ways. Both HIV and malnutrition are most prevalent in 
the poorest areas of the world, and there is a convergence of etiological factors. 
Malnutrition depresses every aspect of immune function. Deficiency of key micro-
nutrients like iron, folic acid, zinc, selenium and vitamins A, C and D also adversely 
affects immune function. Recent research has led to a greater understanding of 
these mechanisms. Immune dysfunction secondary to malnutrition is referred to as 
nutrition-associated immunodeficiency. Hence it is easy to surmise that malnutri-
tion and HIV/AIDs are a deadly duo.
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1. Introduction
HIV/AIDS and malnutrition form a deadly duo with each one fuelling the other. 
Malnutrition increases susceptibility to infection by causing immune dysfunction 
in manifold ways. The depressed immune status can amplify HIV replication and 
accelerate progression of HIV disease to AIDS. Malnutrition increases the risk of 
death on initiation of ART in PLHA, and untreated HIV/AIDS puts individuals at 
risk for malnutrition. The same is more acute in infants and children under 5 years 
of age [1, 2]. Untreated or advanced HIV/AIDS is again associated with a compro-
mised immune status that makes these patients susceptible to opportunistic infec-
tions. Of these, tuberculosis is the most common and most debilitating one. Apart 
from TB, common infections like pneumonia, kala-azar, meningitis and malaria are 
also more common in these patients. Infections and the chronic low-grade inflam-
matory state perpetuated by HIV infection suppress appetite, increase catabolism 
of muscles and push patients towards malnutrition. Loss of strength means low 
earning capacity and loss of livelihood. The social stigma of HIV fractures social 
and family bonds. All of them further push patients towards impoverishment and 
malnutrition.
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2. Magnitude of the problem
A study in 2010 estimated that more than 925 million people in the world were 
undernourished and one-third of the global disease burden could be eliminated 
by adequate nutrition [3]. The greatest burden of malnutrition is seen in the age 
group of 2–5 years. According to 2014 data, 159 million children were stunted and 
50 million were wasted [4]. Among different geographic regions, South Asia and 
sub-Saharan Africa have the highest global burden of malnutrition. In 2014, they 
accounted for 25.1 and 32% of stunted children under 5 years of age, respectively 
[5, 6]. Sub-Saharan Africa suffers from a high burden of undernutrition, affecting 
23.2% of its population, and in 2015 this region accounted for 69% of the estimated 
people living with HIV globally. A review of case records of 4350 children aged 
2 – 19 years enrolled in HIV-care programme in Benin, Burundi, Cameroon, Chad, 
Cote d’Ivoire, Mali and Togo was done in 2011. The mean age was 10 years (IQR 
7 – 13). Anthropometric indices that were measured were height-for-age z-score 
(HAZ) and weight-for-height z-score (WHZ) for children < 5 years and BMI-for-
age z-score (BAZ) for children >5 years. All values were expressed as z-scores. 
About 80% of the children were on ART for a median period of 36 months. The 
prevalence of malnutrition was 42% (95% CI 40–44%). About half of all children 
in the age group of 2–5 were malnourished, and among children in the age groups 
of 5–10 and 10–19, the prevalence was 36 and 44%, respectively. The authors then 
subtyped malnutrition as acute, chronic or mixed. Acute malnutrition was defined 
as WHZ/BAZ < −2SD and HAZ ≥ −2SD. The prevalence of acute, chronic and 
mixed malnutrition was 9 (95% CI 6–12%), 26 (95% CI 23–28%) and 7% (95% CI 
5–10%), respectively. Acute malnutrition was associated with age < 5 years, male 
sex, severe immunodeficiency and absence of ART. Chronic malnutrition was most 
common in children <5 years (37%). The prevalence of chronic malnutrition in the 
age groups 5–10 and 10-19 years was 24% each. Mixed malnutrition was associated 
with male sex, age < 5 years, severe immunodeficiency and recent initiation of 
ART (<6 m) [7]. In another study from Ethiopia, malnutrition was seen in 224 of 
the 372 children with HIV/AIDS (60.2%). Of all the malnourished children, 67.7% 
were males and 52.7% were females. In the age group of 2–5 years, 96.3% were 
malnourished, and in the age groups of 5–10 and 10–15 years, it was 48.3 and 59.2%, 
respectively [8].
In a study from North India, 56.7% of 102 HIV-positive children presenting 
to an ART clinic had protein-energy malnutrition (PEM). Children with higher 
grades of PEM had lower CD4 cell counts [9]. Of the 4105 children initiating ART 
in TREAT Asia Paediatric HIV Observational Database (TApHOD) cohort, 355 
(11.9%) had severe malnutrition (defined as baseline weight-for-height z-score 
of <−3 if aged 6–60 months or BMI-for-age z-score of <−3 if aged 61 months 
to 14 years) [10]. This is very high compared with the estimated prevalence of 
severe malnutrition in the general paediatric population in SE Asia (5.2%) [11]. 
The risk factors for severe malnutrition were age 6–12 months, male sex and prior 
 diagnosis of tuberculosis [10].
Among adult patients, moderate malnutrition is more common than severe 
malnutrition. A study done in Salvador, Brazil, looked at prevalence of malnutrition 
in PLHA in the age group of 20–59 years. One hundred twenty-seven patients were 
enrolled in the study. Malnutrition (BMI < 18.5 kg/m2) was found in 55 (43%) of 
the subjects and severe malnutrition (BMI < 16 kg/m2) in 15%. Lean body mass and 
fat body mass were lower than the fifth percentile of a reference population in 80 
(63%) and 38 (30%) patients, respectively [12]. Another study from Iran compared 
malnutrition among adults with HIV/AIDS with the general population. One hun-
dred PLHA were enrolled in the study. Mild (BMI 17–18.4 kg/m2), moderate (BMI 
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16–6.9 kg/m2) and severe malnutrition (BMI < 16 kg/m2) were seen in 24, 38 and 
15%, respectively. Except for mild malnutrition, all the other figures were signifi-
cantly higher than that for the general population [13]. Data from the Nutrition for 
Healthy Living (NFHL) cohort in Boston, USA, reveals some disturbing facts about 
HIV-malnutrition in the era of HAART. The total prevalence of HIV-associated 
weight loss and wasting in the cohort was 38%. Both weight loss and wasting were 
seen in those who were on a robust ART regimen, those who had failed ART and 
those who were ART-naive. The authors also found that the prevalence of weight 
loss and wasting had not changed over time and that it was as frequent in 2005 as it 
had been in 1997 [14].
3. Impact of HIV-malnutrition: mortality and morbidity
Malnutrition contributes to increased mortality among children, mainly due to 
infections. Children with severe acute malnutrition had 12 times the risk of dying 
when compared with well-nourished children of the same age [15]. HIV infection 
further increases the risk of dying among children with malnutrition. A systematic 
review and meta-analysis of 17 studies on 4891 children with severe acute malnutri-
tion in sub-Saharan Africa revealed that children with HIV infection were more likely 
to die than those not infected with HIV (30.4 vs. 8.4%, P < 0.001, relative risk 2.81, 
95% CI 2.04–3.87) [16]. Non-immunological factors also contribute to increased 
mortality among children with malnutrition. These include impaired respiratory 
excursions due to reduced muscle mass predisposing to chest infections, reduced 
electrolyte absorption from the gut, impaired renal concentration capacity which puts 
the child at risk for dehydration and lastly impaired cardiac function that can cause 
heart failure [17]. The NHFL study showed that for every 1% increase in weight loss 
since the previous visit, the risk of death rose by 11%. When weight loss was >10% 
below the baseline weight, the relative risk of death increased nearly sixfold [14].
4. Aetiopathogenesis of HIV-malnutrition
4.1 HIV infection per se and HIV wasting syndrome
HIV wasting was included as an AIDS-defining criterion (ADC) in 1987 by the 
Centers for Disease Control and Prevention (CDC). HIV wasting is defined as an 
involuntary weight loss of >10% from the baseline and associated with diarrhoea, 
fever or weakness of ≥30 days duration in the absence of a concurrent illness. 
HIV wasting is associated with disease progression and death even when patient 
is on effective ART [18]. Wasting is associated with low serum albumin levels and 
deficiency of important micronutrients like zinc and selenium [13].
The primary cause for weight loss in PLHA is inadequate calorie intake. One 
of the key factors leading to this is anorexia secondary to elevated levels of pro-
inflammatory cytokines like interleukin-1 (IL-1), interleukin-6 (IL-6) and tumour 
necrosis factor-α (TNF-α). These cytokines also cause a rise in total daily energy 
expenditure (TEE) due to an increase in resting metabolic rate (RMR) or resting 
energy expenditure (REE) [19, 20]. RMR may increase by 10–30%, more so in the 
presence of concurrent infections or high viraemia and increased catabolism of 
proteins [14, 21–25]. Macallan et al. evaluated patients with HIV/AIDS for TEE, REE 
and energy intake. The REE was 9.6% higher in HIV-infected men than in HIV-
negative men (25.0 vs. 22.8 kcal/kg/d; p = 0.002). But the mean TEE in HIV-infected 
men was lower than that of the population standard for HIV-negative men between 
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30 and 39 years of age (2750 kcal/d versus 3420 kcal/d) The authors concluded 
that this was due to reduced physical activity. However, there is a net negative 
energy balance because reduced TEE does not offset decreased energy intake due to 
anorexia and malabsorption [19]. Roubenoff and colleagues showed that cytokines 
released from activated PBMCs like TNF-α and IL-1β independently predicted loss 
of lean body mass and changes in REE [26]. And, nutritional and metabolic abnor-
malities correlated better with cytokines from PBMCs than plasma cytokines. Levels 
of TNF-α and IL-1β and IL-6 from PBMCs were better than plasma cytokines in 
distinguishing between participants with or without HIV wasting [27].
4.2 Anorexia
Various causes of anorexia leading to HIV wasting include oral candidiasis, 
oesophageal candidiasis, CMV oesophagitis, fever and tuberculosis. ART is also 
associated with significant adverse effects that include anorexia. Many NRTIs cause 
mitochondrial toxicity. Lactic acidosis and pancreatitis are two of the most serious 
effects of mitochondrial toxicity due to NRTIs, especially didanosine, stavudine 
and zidovudine. Frank lactic acidosis is not common, but hyperlacticacidaemia is 
fairly common and is seen in about 15% of patients on these NRTIs. It manifests 
with anorexia, nausea, weight loss, peripheral lipoatrophy and mildly deranged 
transaminitis. Zidovudine causes anorexia, nausea and fatigue in 5–10% patients 
during the early stages of therapy. Other drugs associated with anorexia and nausea 
include ritonavir and elvitegravir-cobicistat combination [28, 29]. Anorexia may 
also be secondary to jaundice secondary to HBV/HCV coinfection. Many ART 
drugs can cause hepatitis by different mechanisms. NRTIs cause steatohepatitis by 
mitochondrial toxicity. This usually develops after 6 months of treatment. NNRTIs 
cause hepatitis by hypersensitivity reaction. This usually occurs within the first 
2–4 months of therapy. Protease inhibitors may cause hepatitis especially with 
HBV or HCV confection by an unknown mechanism. Anti-tubercular therapy is 
also another significant cause of iatrogenic hepatitis. Alcoholism, drug abuse and 
depression may all be associated with anorexia.
4.3 Chronic diarrhoea
Diarrhoea remains a common complaint among PLHA and adversely affects qual-
ity of life. In the early years of the HIV epidemic, HIV wasting syndrome was a com-
mon presentation, especially in sub-Saharan Africa. It would often be associated with 
prolonged diarrhoea (>30 days duration). Causes for diarrhoea can be infectious and 
non-infectious. In most of the low-income countries, the aetiology continues to be 
infectious, and etiologic agents differ according to geographical region [30, 31]. The 
aetiological agents can be broadly grouped as protozoa, bacteria, fungi and viruses.
4.3.1 Infectious diarrhoea
Cryptosporidium parvum is the most frequently identified protozoan causing 
chronic diarrhoea in PLHA universally [32]. In developing countries, prevalence 
rates of cryptosporidium infection can be as high as 20% [33]. The high prevalence 
is due to sewage/faecal contamination of water sources [34]. Although cryptospo-
ridium is commonly associated with chronic diarrhoea in HIV-positive persons, it 
can also cause cholera-like explosive diarrhoea and intermittent acute and relapsing 
illnesses. Microsporidia (Enterocytozoon bieneusi and Encephalitozoon intestinalis) 
are other important protozoa causing diarrhoea in AIDS patients [35–38]. In a study 
from New York, microsporidia were found in 39% of AIDS patients undergoing 
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gastrointestinal evaluation for diarrhoea [39]. But this high prevalence is uncom-
mon in other parts of the USA and the rest of the world [36]. Isospora belli is an 
endemic gastrointestinal pathogen among PLHA in Haiti, but it is uncommon in the 
USA [36, 37]. The widespread use of trimethoprim-co-trimoxazole prophylaxis for 
Pneumocystis carinii may be the reason for this low prevalence: Isospora being very 
susceptible to trimethoprim-sulphamethoxazole. Cyclospora have also been identified 
in HIV-infected patients with chronic diarrhoea in low- to middle-income countries 
(LMIC) [35–37]. Amoebic dysentery or invasive amoebic disease like liver abscess 
or amoeboma is not more common in PLHA than in the general population even in 
developing countries. A high frequency of stool carriage in asymptomatic homosexual 
men is however common [30]. Stool carriage of amoebae in PLHA includes E. dispar, 
E. hartmanni, E. coli and also non-pathogenic E. histolytica [40]. There is no difference 
in the prevalence or severity of giardiasis among PLHA and HIV-negative populations.
The spectrum of bacterial pathogens causing diarrhoea in HIV-infected patients 
is similar to that in the general population. Salmonella, Shigella, Campylobacter and E. 
coli remain the commonest causes of diarrhoea in PLHA also. The immunocompro-
mised state can lead to a symptomatic carriage of Shigella and Campylobacter [30]. 
Clostridium difficile should be actively excluded in patients with recent history of 
antibiotic therapy [41]. Clostridial infection is more common in severely immuno-
compromised patients (CD4+ T-cell count <50/ mm3). Mycobacterium avium complex 
(MAC) typically causes diarrhoea in patients with AIDS with profound immunosup-
pression (i.e. CD4+ T-cell count <50 cells/mm3) [42]. Features of systemic involve-
ment in the form of fever and weight loss often accompany diarrhoea [43]. MAC 
usually involves the small intestine; however, it can affect the entire GI tract [44, 45].
Fungi are rare etiologic agents for diarrhoea in HIV-infected. The only exception 
is histoplasmosis which can infect all parts of the GIT; can cause fever, weight loss 
and diarrhoea; and may require hospitalisation [46].
Cytomegalovirus (CMV) was identified in as many as 45% of GI biopsies in AIDS 
patients with diarrhoea in a study from France [47]. CMV infection usually presents 
late in the natural history of HIV/AIDS, occurring when CD4 count is <100 cells/
mm3. In contrast, CMV was not detected in any of the rectal biopsies from 29 African 
patients with chronic diarrhoea and abnormally appearing rectal mucosa [48]. 
Other viruses that have been identified in stools of PLHA with chronic diarrhoea 
include adenovirus, rotavirus, astrovirus, picornavirus and coronavirus [49, 50]. An 
Italian study followed up a cohort of 50 HIV-negative and 10 HIV-positive children 
for 1 year and collected stool samples from the children every alternate week. The 
samples were tested for rotavirus (RV), and they found that while HIV-positive 
children shed more RV in stools, these rotaviral infections were not more often 
associated with diarrhoea than in HIV-negative children [51]. Similar prevalence was 
also reported from Lusaka in Zambia and Baltimore in the USA [52, 53].
Chronic Strongyloides infection may be present as chronic diarrhoea. 
Strongyloides hyper-infection can occur in the immunocompromised. Disseminated 
Strongyloides infection leads to migration of larvae into various tissues outside the 
gut. The migrating larvae carry gut bacteria along, leading to bacterial translocation 
which can trigger systemic inflammation and sepsis [54].
4.3.2 Non-infectious diarrhoea
4.3.2.1 ART-induced diarrhoea
With early diagnosis and institution of antiretroviral therapy, the incidence of 
infective diarrhoea has declined, and non-infectious causes are being increasingly 
identified. The common causes now are ART-associated diarrhoea, HIV enteropathy 
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and causes seen in the general population. About 60% of patients receiving ART 
gave history of diarrhoea in the previous month [55]. Data from clinical trials sug-
gest that up to 19% of these events may have been due to the adverse effects of ART 
[56]. Among the ART drugs, protease inhibitors (PIs) seem to be most strongly 
associated with diarrhoea. In mouse models, PIs and reverse transcriptase inhibi-
tors significantly increased water and electrolyte secretion into intestinal lumen 
in vivo [57]. Rufo and colleagues demonstrated that protease inhibitors in general, 
and nelfinavir in particular, potentiate signalling through muscarinic and calcium-
dependent receptors of intestinal cells leading to increased chloride secretion into 
the lumen [58]. Stool samples of these patients also had increased concentrations of 
sodium and chloride consistent with secretory diarrhoea. In an in vitro study, Bode 
and colleagues showed that PIs induced apoptosis of human intestinal epithelium, 
thereby compromising barrier function and increasing water secretion in gut lumen. 
Decreased alkaline phosphatase activity in cells exposed to PIs led to accumulation of 
unfolded proteins in the cytosol. A failure of the cell’s ‘unfolded protein response’, a 
specific signalling pathway aimed at returning the cell’s protein folding function back 
to normal, triggered cellular apoptosis [59]. Wu and colleagues found that lopinavir 
and ritonavir induced endoplasmic reticulum dysfunction in intestinal epithelial cells 
that led to diarrhoea [60].
4.3.2.2 HIV enteropathy
HIV enteropathy is an idiopathic form of diarrhoea observed in all stages of HIV 
disease in the absence of an infectious source and with characteristic histologic 
features [61–63]. Changes include crypt epithelial proliferation leading to increased 
crypt height, later crypt cell encroachment onto villi and relative decreased vil-
lous height. The consequence of these changes are diarrhoea and malabsorption 
[64, 65]. While the exact mechanisms by which these changes occur in the GI tract 
are unclear, HIV has been postulated to alter signalling and cellular structure, 
which may lead to architectural distortion [61]. Keating and colleagues investigated 
monosaccharide absorption in patients with HIV and AIDS. They demonstrated 
that patients with diarrhoea had significant malabsorption of all monosaccharides 
tested [66]. Malabsorption occurred irrespective of pathogen-positive or pathogen-
negative diarrhoea, indicating that HIV had an independent direct role. This may be 
due to the ability of HIV to infect mucosal epithelial cells [67]. Increased mucosal 
infiltration by activated CD8+ T cells results in high levels of pro-inflammatory 
cytokines which can directly damage the mucosal barrier [61, 63]. Other hypotheses 
for the mechanism of HIV enteropathy include decreased transepithelial electrical 
resistance, decreased sodium-dependent glucose absorption and increased inter-
cellular permeability in HIV-infected cells [68]. HIV enteropathy can also lead to 
malabsorption of vitamin B12, bile acid and monosaccharides [61, 64, 68].
4.4 Environmental enteric dysfunction
Chronic diarrhoea, water, sanitation and hygiene (WASH) have been impli-
cated as causative factors for severe stunting in low- and middle-income countries 
for a long time. Efficacy of WASH interventions in reducing diarrhoea and mal-
nutrition has been lower than expected. This led to the search for another cause. 
Today, there is sufficient evidence that the cause is environmental enteric dysfunc-
tion (EED). It is ‘an apparently seasonal and reversible disorder characterised by 
gut mucosal cell villous atrophy, crypt hyperplasia, increased permeability and 
increased inflammatory cell infiltrate’. The principal driver of EED is the high 
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burden of intestinal infectious disease which is not enough to cause diarrhoea but 
enough to induce a state of chronic immune activation in the gut mucosa, thereby 
leading to epithelial damage. Dysbiosis of gut microbiota is also now considered to 
have an important role. The pathogenesis is probably chronic exposure to patho-
gens leading to a T cell-mediated immune response in the gut which continues 
to remain in an inflammatory hyperimmune state. This exaggerated immune 
response leads to structural changes in the gut mucosa, increased inflammation 
and permeability of the intestines, resulting in disrupted gut immune response; 
reduced absorption, delivery and utilisation of nutrients; and finally nutritional 
deficiency. There are also features of systemic inflammation, microbial transloca-
tion (MT) across the permeable gut mucosa and changes in the gut microbiome. 
Malnutrition further impairs the renewal of gut mucosal cells, maturation and 
proliferation of intestinal cells and pancreatic islet cells. The chronic low-grade 
inflammation inhibits endochondral ossification, thus inhibiting bone growth and 
leads to stunting [69].
The pathological hallmark of EED is villus blunting, which means that in 
histological sections villus height is reduced and villus width increased. Increased 
intestinal permeability can be detected using disaccharide probes. This is consid-
ered a diagnostic hallmark of EED. In adults confocal laser endomicroscopy (CLE) 
can be used to detect leakage of fluorescein dye from systemic circulation into the 
gut lumen. In adults with EED, CLE shows extensive leakage into the gut lumen 
occurring especially at the villous tips. This suggests that micro-erosions secondary 
to disordered epithelial cell shedding may be an important cause for the increased 
permeability [70]. The increased permeability leads to malabsorption of nutrients 
and also microbial translocation (MT) from the lumen into systemic circulation 
via gut mucosa. This MT is also important in perpetuating a chronic inflammatory 
state. Due to MT, some important biomarkers of MT are now being used to detect 
EED. These include bacterial cell wall lipopolysaccharide (LPS), soluble lipopoly-
saccharide co-receptor (sCD14) and antibodies to the LPS core antigen (EndoCAb) 
[71]. The clinical impact of EE, apart from stunting, is decreased immunological 
response to oral vaccines.
Does EED fuel HIV replication and disease progression? It is attractive to think 
it does so. Aggregation of intraepithelial lymphocytes and lamina propria T-cell 
populations has been described in children with EED. The T cells expressed CD69 
and HLA-DR. Children with EED had 4–5 times more CD3+ T cells and 15–30-fold 
higher number of CD25+ T cells in the lamina propria than the UK controls. They 
also had a higher proportion of T cells than TCRαδ+ [72]. Activated lymphocytes 
in a milieu rich in inflammatory cytokines would be the perfect ground for HIV 
attachment and replication. However there have been no studies to prove or dis-
prove this. But Jacob and his colleagues have demonstrated that the dominant effect 
of HIV on enteric mucosa is to increase villous crypt depth [73]. Hence HIV and 
EED may work synergistically to aggravate malnutrition.
4.5 Oral ulcers
Recurrent and severe oral ulcers make eating uncomfortable and painful. 
Decreased food intake over a period of time can precipitate malnutrition. Oral 
candidiasis is the most frequent oral disease associated AIDS, with a prevalence 
of 70–90% [74–76]. It often occurs early in the course of the disease. With decline 
in immune status, its frequency and severity worsens, and it may occur along 
with oesophageal candidiasis. Recurrent major aphthous ulcers and herpetiform 
aphthous ulcers are painful and adversely affect food intake. Other conditions like 
Kaposi sarcoma are becoming uncommon now.
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4.6 Tuberculosis
Coinfection with HIV and Mycobacterium tuberculosis (TB) is an extremely com-
mon problem. TB is the largest single cause of death in HIV-positive individuals, 
and, in areas of high prevalence, it is the most common coinfection in HIV-positive 
children. HIV and TB pathogens interact, resulting in an accelerated clinical course 
and premature death. TB infection results in secondary wasting. Indeed, weight 
loss is the presenting feature in almost 50% of cases of TB, and persistent anorexia 
is a feature in approximately one-quarter. Swaminathan, Padmapriyadarsini and 
colleagues studied the nutritional status of HIV-positive subjects with TB (n = 174) 
and HIV-positive ones without TB (n = 488). They compared their nutritional status 
to that of HIV-negative people of the same socioeconomic status (n = 160). They 
found that 50% of HIV-positive subjects with TB and one-third of HIV-positive 
subjects without TB had a BMI of <18.5 kg/m2. Moreover, HIV-positive subjects both 
with and without TB had lower mid-arm circumference, hip circumference and 
waist circumference than HIV-negative individuals. HIV-positive people with TB 
remained underweight even after adequate treatment for TB underscoring the nega-
tive impact of TB on the nutritional status of these people and also the synergistic 
effect of HIV-TB confection in aggravating malnutrition [77]. Furthermore, malnu-
trition is a risk factor for the acquisition of primary TB infection, as well as progres-
sion to active disease [78–80]. Other infections—particularly pneumonias, which 
are very common in HIV-positive children—have also been found to contribute to 
the increased risk of malnutrition in children in several lower-income countries.
4.7 HIV endocrinopathies
Adrenal insufficiency is the commonest endocrinopathy in the HIV-infected. The 
mechanism of primary adrenal insufficiency in the HIV-infected is twofold: HIV 
adrenalitis and adrenal gland destruction secondary to tuberculosis, CMV or other 
opportunistic infections [81]. Sepsis may also precipitate acute adrenal insufficiency. 
Adrenal insufficiency can also be iatrogenic, triggered by drugs like ketoconazole 
and rifampicin [82]. Secondary adrenal insufficiency can be due to the direct effect 
of HIV on the hypothalamic-pituitary-adrenal (HPA) axis also. Cytokines like inter-
leukin-1 (IL-1), IL-6 (in a synergistic manner) and TNF-α can suppress the HPA 
[83]. HIV-positive patients who develop adrenal insufficiency may present either 
acutely or chronically. Acute insufficiency manifests in the critically ill as Addisonian 
crisis characterised by profound hypotension. In our study on hypoadrenalism in 
the HIV-infected with current or past tuberculosis, it was found that certain clinical 
features occurred consistently. They included history of fatigue, lethargy, muscle 
weakness, low mood/irritability, significant weight loss and need to micturate fre-
quently and findings of hypotension, both resting and postural and pale skin (under 
publication). The prevalence of hypoadrenalism in HIV and HIV-TB varies from 20 
to 70%. This is mainly because many studies were only done on critically ill patients 
in the hospital. The use of standard and low-dose ACTH stimulation test also made a 
difference in pickup. Nevertheless, wasting in an HIV-positive patient should trigger 
a search for adrenal insufficiency. On the other hand, in one study it was seen that 
testosterone deficiency does not lead to significant wasting [26].
4.8 Co-trimoxazole prophylaxis (CPT)
Severe acute malnutrition (SAM) contributes to 1 million childhood deaths 
annually worldwide, and its treatment is a key strategy for reducing childhood 
mortality [84]. Infectious disease is thought to be the main mediator of mortality 
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in children with SAM. Trehan and colleagues studied the efficacy of empirical 
antimicrobial therapy in children with severe acute malnutrition but without 
clinical features of infection. Two thousand seven hundred sixty-seven children in 
the age group of 6–59 months were randomised into three arms. One received oral 
amoxycillin, the other cefdinir and the last group a placebo for 7 days. Twelve-week 
mortality rates for the three groups were 4.8, 4.1 and 7.2%, respectively. The relative 
risk for death for placebo compared with amoxycillin was 1.55 (95% CI 0.7–2.24) 
and for placebo compared with cefdinir was 1.80 (95% CI 1.22–2.64). Differences in 
mortality and recovery were not statistically different between the amoxycillin and 
cefdinir arms [85].
Daily co-trimoxazole prophylaxis reduced all-cause mortality and hospital 
admissions in children with HIV/AIDS. This was despite high levels of antimicrobial 
resistance being identified in vitro among invasive isolates at study sites [86, 87]. 
Co-trimoxazole protected HIV-infected children against malaria, pneumonia and 
sepsis [88]. Other studies have shown its role in preventing recurrent urinary tract 
infections, pneumonia in children with measles and infections in children with 
specific immunodeficiencies [89–91]. Prendergast and colleagues reported that 
co-trimoxazole prophylaxis retards decline in weight and height for age in HIV-
infected children, not on ART [92]. Boettiger and colleagues also found that CPT 
may enhance weight recovery in children with malnutrition on ART [10]. In both 
HIV-infected and malnourished children, the beneficial effect of antimicrobial 
therapy is primarily due to prevention and treatment of infections. Other collateral 
benefits could be reduction of inflammation which would reduce diversion of 
nutrients and decreased cytokine-mediated growth retardation and also reduced 
enteropathy and perturbations of gut flora [93].
4.9 Substance abuse and psychiatric disorders
HIV infection and chronic drug abuse both compromise nutritional status. 
There is a synergistic effect in HIV-positive drug users that leads to wasting and 
significantly impacts mortality. Illicit drug use may interfere with nutrient absorp-
tion, mute appetite and alter metabolism. Lifestyle of chronic drug users may 
compromise their access to food, food selection, housing, family and social sup-
port [94]. Use of injection drugs correlated with lower protein intake in the NFHL 
cohort study [14]. IV drug can be associated with HIV-HBV or HIV-HCV coinfec-
tions. Patients with hepatitis frequently lose weight and develop anaemia and 
neutropenia. As liver disease advances, anorexia, dietary intolerance and limitation 
of nutrient intake occur [95, 96]. AIDS-related dementia and neuropsychiatric 
disorders can cause malnutrition as the ability of patients to care for themselves is 
compromised. Many may forget to eat and others may be unable to prepare bal-
anced meals [97].
4.10 Socioeconomic factors
4.10.1 Food insecurity
Wasting and malnutrition in HIV-positive children is not only due to the HIV 
disease or opportunistic infections. It is also due to breakdown of family structure 
and the failure of social and healthcare systems. Food insecurity is defined as a lack 
of access to sufficient, safe and nutritious food to meet dietary needs and maintain 
a healthy and active life [98]. Another way of defining it is ‘insufficient quantity or 
quality of food, reductions of food intake, and feelings of uncertainty, anxiety, or 
shame over food’ [99].
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There is a high prevalence of food insecurity among PLHA. An American 
study reported that about 50% of PLHA on ART in San Francisco, Atlanta and 
Vancouver were food insecure [100, 101]. In the NFHL cohort from Boston, 36.1% 
participants were classified as ‘food insecure’ [14]. A study done in Senegal com-
pared the prevalence of food insecurity among general population and PLHA in 
two different regions of Senegal: Dakar where the predominant source of income 
was nonagricultural business and Ziguinchor in Casamance province where it was 
agriculture. The prevalence of food insecurity among PLHA in the two regions was 
much higher being 84.6 and 89.5%, respectively, than in the general population 
(16–60%). The prevalence of severe food insecurity was 59.6 and 75.4% in Dakar 
and Ziguinchor, respectively [102]. Similar findings are reported from both urban 
and rural settings in other parts of Africa. Among 898 PLHA on ART in Kinshasa, 
Democratic Republic of Congo, 57% of the people were food insecure and 50.9% 
were severely food insecure [103]. The prevalence is higher in other studies. In one 
from Windhoek, Namibia, 92% of 390 PLHA on ART were food insecure, and 67% 
were severely food insecure [104]. In a big study involving 76,038 HIV-infected 
people in Western Kenya, the prevalence of food insecurity ranged from 20 to 50% 
[105]. The prevalence of food insecurity in rural Uganda and North Ethiopia were 
74.5 and 40.4%, respectively [106, 107].
Food insecurity is linked to lower educational levels and low socioeconomic 
status, unemployment, larger household size and number of children [108, 109]. 
Andrade and colleagues found that daily per capita income correlates well with 
malnutrition in Salvador, Brazil. They found that for daily per capital incomes 
of <US$ 2, US$ 2–4.99 and US$ 5–9.99, the prevalence of malnutrition increased 
by 2.01 (95% CI 1.06–3.81), 1.75 (95% CI 0.92–3.35) and 1.42 (95% CI 0.76–2.65) 
times, respectively, compared to the patients whose per capita household income 
was US$ ≥10.00 per day [12]. The presence of even one HIV-positive person in a 
family pushes the family to food insecurity in Africa [110]. In most of Africa, South 
America and Asia, women are the primary caregivers in households. They procure 
foodstuffs, gather firewood, prepare food and feed the children. Not surprisingly, 
the risk of malnutrition in children increases if the mother has HIV/AIDS. Timely 
provision of ART to HIV-positive women reduces under-5 mortality rates to those 
similar to children of HIV-negative women.
HIV/AIDS is a major factor leading to food insecurity. The disease leads to debil-
ity of family members in the prime of their life. This leads to loss of jobs, reduced 
productivity and increased caregiver burden. In turn, food insecurity has many 
adverse effects on health and well-being of PLHA. It leads to risky coping strategies 
in households with HIV-positive individuals. Wages get directed to purchase of 
ART, and many family members may exchange sex for money or food, thereby put-
ting themselves at higher risk of acquiring HIV infection and STDs. It also increases 
risk of vertical transmission of HIV by risky infant-feeding practices. It increases 
non-adherence to ART, aggravates adverse effects of ART, and leads to incomplete 
viral suppression, worsening health and increased mortality [111, 112]. In DRC and 
Namibia, food insecurity was associated with increased odds of poor adherence to 
ART (adjusted odds ratio 2.06 and odds ratio 3.84) [103, 104].
4.10.2 Poor weaning practices.
Mothers’ level of education influences occurrence of malnutrition in children. 
Poor education leads to lack of awareness of the importance of exclusive breast 
feeding for the first 6 months of the infant’s life, failure to introduce complementary 
feeds at 6 months and limited food diversity. It also contributes to adherence to local 
taboos with regard to refraining from giving foods of animal origin to children.  
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In addition, lack of access to food supplements for HIV-positive children also contrib-
utes to malnutrition among these children in many parts of Africa [113]. Exclusive 
breast feeding during first 6 weeks of life resulted in consistently higher z-scores for 
weight at 52 weeks of age in HIV-infected infants than in those on only top feeds or 
mixed feeds (difference of 130 g for male children and 110 g for female children) [1].
5. Pathobiology of immunodeficiency in malnutrition
Malnutrition is considered to be the commonest cause of immunodeficiency in 
the world. It adversely impacts every aspect of immune function. All these immune 
dysfunctions are collectively referred to as nutritional-acquired immunodeficiency 
syndrome (NAIDS). Understanding of malnutrition-related immunodeficiency can 
shed a lot of insight into immunodeficiency of HIV/AIDS.
Profound thymic atrophy with depletion of thymocytes and changes in thymic 
extracellular matrix are seen even in moderate malnutrition. It is however difficult 
to say whether these changes in thymic function are due to malnutrition per se or 
due to the severe infections frequently associated with malnutrition. Changes in 
thymic micro-environment like decreased thymic epithelial cells, expansion of 
extracellular matrix and decreased production of thymic hormone all contribute to 
thymic depletion. Thymocyte depletion results from increased apoptosis of CD4 
and CD8 double-positive, double-negative and single-positive (immature) thymic 
lymphocytes. Apoptosis is driven by increased circulating levels of glucocorticoids, 
reduced leptin levels and deficiency of dietary protein and zinc.
Bone marrow cellularity is reduced, its stroma altered and there is limitation of 
extra-cellular matrix expansion. A study on bone marrow changes in children with 
PEM showed erythroid hypoplasia/dysplasia in the marrows of 50% children with 
kwashiorkor, 30% children with marasmic-kwashiorkor and 28.5% children  
with marasmus [114]. Suppression of cell cycle progression of haematopoietic 
progenitor cells with cell cycle arrest in G0/G1 phase is seen in protein malnutri-
tion. This results in reduction in red cell and white cell lineages. In addition, bone 
marrow granulocytes display impaired blastic response to granulocyte-colony 
stimulating factor (G-CSF) and suboptimal mobilisation on lipopolysaccharide 
challenge. In protein-deficient mice models, bone marrow mesenchymal cells tend 
to differentiate into adipose cells, thereby altering the cytokine micro-environment 
in the bone marrow and compromising haematopoiesis. Despite this, the total 
number of leucocytes in peripheral blood of children with severe acute malnutrition 
remains normal. However, the number of dendritic cells is reduced [115]. Mice with 
transferrin receptor-1 deficiency are unable to absorb adequate iron. This results in 
impaired T-cell development and fewer mature B cells [116].
 Secondary lymphoid tissue in the spleen and lymph nodes shows similar 
degenerative and hypo-proliferative changes in mouse protein-deficient models. 
The spleen has a thickened capsule and is deficient in splenocytes and splenic 
mononuclear cells. Cell cycle arrest, similar to that seen in the bone marrow, is seen. 
Splenic white pulp is also disorganised. Changes in lymph nodes can be seen even 
in moderate malnutrition. Zinc and iron deficiencies exaggerate changes caused 
by protein-energy malnutrition. There is hypoplasia of lymph nodes, decreased 
number of dendritic cells, macrophages, neutrophils and fibroblasts. The ability of 
lymph nodes to act as an effective barrier to pathogen spread is compromised. Poor 
trafficking of soluble antigens through the lymphoid conduits is also seen.
It would be intuitive to assume that like all other lymphoid tissue, the gut-
associated lymphoid tissue (GALT) should also be hypoplastic in malnutrition. This 
has not been shown in humans conclusively.
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5.1 Innate immune system dysfunction in malnutrition
Malnutrition affects the primary physical defensive barrier of the body. 
Thinning of dermis and reduced collagen levels are seen in animal models of 
PEM. In marasmic mice, thinning of the epidermis, with decreased hydration of 
stratum corneum, and decreased epidermal proliferation are seen. Wound healing 
is delayed and there is delayed wound contraction. Increased infiltration of wound 
site with inflammatory cells, decreased laying down of collagen, oedema of the 
extracellular matrix and altered neovascularisation are seen. Though skin changes 
like oedema and ‘flaky paint dermatosis’ and desquamation are common in kwashi-
orkor, there is no definite clinical proof to associate these changes with decreased 
immunity.
The changes in gut mucosa are more dramatic and have greater clinical conse-
quences. These have been discussed above in environmental enteric dysfunction. 
At this juncture it suffices to say that gastric acid secretion is decreased in severe 
malnutrition, and gut permeability to bacteria is increased. In the oral cavity flow 
of saliva is reduced. Vitamin A deficiency reduces differentiation of epithelial cells 
in the skin, cornea and respiratory, urogenital and gastrointestinal tracts. This 
compromised epithelial barrier makes bacterial and viral invasion easy. Retinoic 
acid deficiency can alter gut mucosal barrier function. There is a marked reduc-
tion of type 3 innate lymphoid cells (ILC3) in gut mucosa of mice with vitamin 
A deficiency resulting in decreased production of IL-17 and Il-22 and increased 
susceptibility to bacterial infections. Concomitantly, there is an expansion of type 
2 innate lymphoid cells (ILC2). These cells secrete IL-13 which causes goblet cell 
hyperplasia, increased mucus production and an increased resistance to gut hel-
minths. Zinc reduces biofilm formation and decreases expression of virulence and 
adherence factors of entero-aggregative Escherichia coli. This may be one of the rea-
sons for frequent diarrhoeal illnesses in malnourished children. A double-blinded 
randomised placebo controlled trial on zinc supplementation in children between 
the ages of 6 and 30 months in Delhi showed reduction in frequency, severity and 
duration of diarrhoea disease in the zinc-supplemented group [117].
Acute-phase reactant synthesis seems unaffected by malnutrition. C-reactive 
protein (CRP) rise is similar in normal and malnourished children when faced with 
an infectious challenge [118]. In contrast the so-called negative phase reactants 
like transferrin, pre-albumin, fibronectin and α2-HS glycoprotein are consistently 
decreased in malnutrition and do not rise adequately during an infectious chal-
lenge [119]. Complement levels are decreased in severe malnutrition. This is due to 
reduced synthesis in the liver and also increased consumption in the periphery. This 
is most marked in kwashiorkor. Reduction in C3 levels in malnutrition has been 
consistently reported from other studies as well [120].
As it has already been mentioned, there is no reduction in the total number 
of leucocytes in the peripheral blood. But chemotaxis and microbicidal activity 
of neutrophils are decreased in children with PEM. This may partly be due to 
decreased lysosomal enzyme synthesis and reduced glycolytic activity. Vitamin 
A is important for neutrophil maturation. Neutrophils in retinoic acid-deficient 
mouse models show impaired chemotaxis, phagocytosis and generation of reac-
tive oxygen species. Vitamin A deficiency also decreases number and function of 
NK cells. Vitamin C deficiency in animals decreases apoptosis of neutrophils and 
results in their decreased clearance. Vitamin C deficiency exaggerates inflammation 
and retards its resolution in mouse model of sterile inflammation. Administration 
of vitamin C attenuates lung, kidney and liver injury in murine models of intra-
abdominal sepsis and lethal LPS administration. The salutary effects of vitamin C 
in the lung include reduced pro-inflammatory response, increased epithelial barrier 
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function, increased alveolar fluid clearance and decreased coagulopathy. Zinc 
modulates respiratory bursts in neutrophils. Moderate to severe malnutrition does 
not lead to reduction in absolute number of natural killer (NK) cells in children, 
but their function is depressed. Iron deficiency impairs macrophage function. 
Intracellular iron activates nuclear factor kB (NF kB). NfkB is responsible for 
exerting a restraint on reactive oxygen species and c-Jun-N-terminal kinase (JNK) 
signalling. These signalling pathways are crucial for antagonism of programmed cell 
death (PCD) induced by pro-inflammatory cytokines. Hypoxia-inducible factor-1α 
(HIF-1α) is an iron-dependent transcription factor that promotes synthesis of 
antimicrobial peptides by macrophages. Hence iron deficiency can lead to apoptosis 
of macrophages and also blunt their anti-microbial activity [121, 122].
Folate deficiency in rats is associated with reduced number of neutrophils and 
eosinophils. Zinc regulates release of pro-inflammatory cytokines like IL-1β, IL-6 
and IFN-α by innate immune cells, and its deficiency leads to reduced synthesis of 
Th-1 cytokines. Selenium exerts its antioxidant activity via selenoproteins. They 
regulate pro-inflammatory mediators via mitogen-activated protein kinase and per-
oxisome proliferator-activated receptor-γ. Genetic knockout of selenoprotein genes 
in mice leads to impaired migration of macrophages and neutrophils and reduced 
phagocyte oxidative burst. Vitamin D plays a crucial role in macrophage function. 
Its deficiency increases risk of active TB and also increases risk of relapse of TB in 
both HIV-uninfected and HIV-positive individuals. The primary action of vitamin 
D is exerted via the vitamin D receptors on macrophages. There is a supplementary 
action via toll-like receptor signalling. Vitamin D leads to increased production 
of cathelicidin and β2-defensin which increase secretion of pro-inflammatory 
cytokines, induce anti-tuberculous autophagy and restrict growth of mycobacteria 
inside macrophages [123].
In severe malnutrition, dendritic cell numbers are reduced in peripheral blood 
and in lymphoid tissues. A study from Zambia showed reduced numbers of DCs 
and also impaired DC maturation and impaired ability of DCs to stimulated T-cell 
proliferation in the face of endotoxaemia. The DC function normalised with 
nutritional therapy [115]. Murine models with deficiency of protein, iron and zinc 
have shown reduction in number resident DCs in lymph nodes. These DCs also 
showed dysregulation of DC chemoattractants during inflammation. PEM grossly 
impairs antigen-presenting capacity and T-cell activation ability of DCs. Vitamin 
A, as retinoic acid, is vital for DC function. When there is inflammation, retinoic 
acid accelerates maturation and antigen-presenting capacity of DCs. Dendritic cells 
also store and release retinoic acid to act on other immune cells. Vitamin D plays an 
important role in regulation of DC function and exerts an anti-inflammatory role. It 
retards DC maturation, antigen presentation and T-cell priming.
5.2 Malnutrition and adaptive immune system
Malnutrition does not affect the total number of lymphocytes in peripheral 
blood. The total levels of immunoglobulins IgG and IgM in blood and secretory IgA 
in duodenal fluid and urine are unaltered. When malnutrition in children is com-
pounded by a severe respiratory or intestinal bacterial infection, the number of B 
cells is reduced when compared to infected but well-nourished children. B lympho-
cyte function is preserved in PEM, but the profile of secreted immunoglobulins 
(Igs) and specific antibody-mediated immune responses are altered. Levels of 
Th1-type immunoglobulins (IgG2a and IgG3) are unaltered, those of tTh2-type Igs 
(IgG1 and IgE) are raised and those of secretory IgA are reduced. Severe protein 
malnutrition leads to decreased levels of secretory IgA in tears and saliva. Zinc 
deficiency depletes cells of B-cell lineage in the bone marrow. Vitamin A-deficient 
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mice show a poor IgG response which is reversible by vitamin A supplementation. 
Vitamin A-deficient mice also have decreased number of IgA-secreting plasma cells 
in their Peyer’s patches [123, 124].
Levels of CD4+ and CD8+ cells in peripheral blood remain unaltered in mal-
nourished children hospitalised with serious infections. But there is a decrease in 
the number of CD4+ CD45RO+ memory T cells and effector T cells (CD4+ CD62L− 
and CD8+ CD28−) in severe malnutrition. Th1 cytokines required for Th1 differen-
tiation (IL-7, IL-12, IL-18 and IL-21) and function (IL-2 and IFN-γ) are reduced in 
peripheral blood mononuclear cells of children with malnutrition and severe infec-
tion. In the same children, an overexpression of Th2 cytokines (IL-4 and IL-10) and 
increased apoptosis of CD3+ T cells is noted. The ability of T cells to respond to an 
inflammatory stimulus is also altered. There is an impaired antigen-specific T-cell 
response (decreased CD8+ cells and decreased IL-2 production by CD4+ cells), 
but antigen-specific antibody production is unimpaired. Proliferative response to 
phytohaemagglutinin is reduced. Delayed-type hypersensitivity response is also 
impaired in severe malnutrition. Zinc is required for Th1 differentiation and Th1 
responses. It increases expression of IL-2, IFN-γ and IL-2Rb β2. Zinc deficiency 
therefore results in a reduction of CD4/CD8 ratio and levels of Th1 cytokines. 
Selenium deficiency adversely affects CD4+ T-cell proliferation, activation and 
function. The production of IL-2 and expression of IL-2 receptor are both reduced, 
and there is impaired mobilisation of calcium. Retinoic acid acts on naive T cells and 
promotes expression of gut-homing receptors, differentiation into Th2 phenotype 
and T-regulatory cells especially in the gut mucosa. It also inhibits maturation to 
Th1 phenotype or Th17 cells. RA activates B cells in mucosa and GALT to transform 
into IgA+ antibody secreting cells (ASC). Hence RA deficiency can seriously impair 
gut mucosal immunity. Due to its influence on effector T-cell function, vitamin A 
deficiency can lead to inadequate immune response to some vaccines. Vitamin A 
supplementation has been shown to lead to 20–30% reduction in all-cause mortality 
and reduction of incidence and severity diarrhoea diseases and measles [125, 126].
The effect of HIV infection on immune systems mirrors that of malnutrition in 
most aspects with just a few key differences. Natural killer cell activity and comple-
ment activity are increased in HIV infection. There is an increased secretion of 
pro-inflammatory cytokines (IL-1β, TNF-α, INF-γ and IL-6, IL-8 and soluble IL-2 
receptors) and reduction of anti-inflammatory cytokines (IL-1 receptor antagonist, 
IL-4, IL-10 and IL-13). The chronic inflammatory state is also a hypercatabolic 
one and leads to increased mobilisation of amino acids from skeletal muscles that 
are further used for gluconeogenesis in the liver. TNF-α and IFN-γ also suppress 
appetite leading to decreased food intake. Hypercatabolism and decreased diet 
lead to malnutrition and HIV wasting. The combination of HIV and malnutrition 
aggravates reduction of CD4 and CD8 T cells, impairs bactericidal function of 
neutrophils and macrophages, impairs delayed-type hypersensitivity response and 
blunts antibody response to immunisation [97].
HIV infection also has a direct impact on nutrition. Studies have shown that 
among asymptomatic HIV-positive children, the rates of protein, carbohydrate and 
fat malabsorption are 30–60, 32 and 30%, respectively [127, 128]. Increased protein 
turnover occurs to cater for proliferation of neutrophils, fibroblasts and lympho-
cytes, production of immunoglobulins and acute-phase reactants and increased 
urinary nitrogen loss. This mainly comes from increased skeletal muscle breakdown 
and increased hepatic protein synthesis. Other metabolic changes that occur include 
elevated hepatic fatty acid synthesis, decreased peripheral lipoprotein lipase activ-
ity, hypertriglyceridemia, increased gluconeogenesis, insulin resistance and hyper-
glycaemia. There is redistribution of body stores of iron and zinc, with both being 
mobilised to the liver. This along with inadequate dietary intake leads to iron and 
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zinc deficiencies. The pro-inflammatory state also leads to increased consumption 
of vitamins A, C and E which serve as antioxidants. There is reduction in levels of 
glutathione which is the principal intracellular antioxidant compound. Deficiencies 
of micronutrients like selenium, zinc, manganese and copper affect function of 
many key antioxidant enzymes. Deficiency of antioxidants leads to increased oxida-
tive stress which triggers T-cell apoptosis and also enhances HIV replication [129].
6. Conclusion
Malnutrition depresses all aspects of immune function. HIV infection can lead 
to wasting and malnutrition by a complex interplay of aetiological factors. This 
malnutrition compounds immunodeficiency of AIDS and accelerates progression of 
disease and increases risk of mortality. Addressing nutrition right from the time of 
HIV diagnosis is a good strategy. Judicious and monitored nutritional therapy can 
mitigate NIADS and improve HIV clinical outcomes.
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